Go Pro

Karyopharm Therapeutics (KPTI) Insider Trading & Ownership

Karyopharm Therapeutics logo
$9.51 +0.13 (+1.39%)
Closing price 07/17/2026 04:00 PM Eastern
Extended Trading
$9.11 -0.40 (-4.24%)
As of 07/17/2026 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Karyopharm Therapeutics (NASDAQ:KPTI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.68%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$19.04K
Get KPTI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Karyopharm Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KPTI Insider Buying and Selling by Quarter

Karyopharm Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/21/2026Sell449$8.94$4,014.06  
1/28/2026
Kristin Abate
CAO
Sell50$7.03$351.50  
1/21/2026
Kristin Abate
CAO
Sell265$5.96$1,579.40  
10/1/2025
Kristin Abate
CAO
Sell362$6.30$2,280.60  
9/15/2025
Kristin Abate
CAO
Sell23$6.43$147.89  
9/15/2025Sell234$6.43$1,504.62  
9/15/2025Sell408$6.43$2,623.44  
9/15/2025Sell325$6.43$2,089.75  
9/15/2025Sell401$6.43$2,578.43  
9/3/2025
Kristin Abate
CAO
Sell12$6.78$81.36  
This tiny piece of glass could be bigger than GPUs (Ad)

Jensen Huang says AI can't scale without it. Google Ventures calls it the future of AI compute. Sequoia Capital - the firm behind Anthropic and OpenAI - calls it a 'holy grail.' It's smaller than a fingertip and made of glass. Wall Street insider Jason Bodner - who called Nvidia at $4.50 - believes this 'light-speed' device could be bigger for AI than GPUs and is about to launch a new wave of winners. He's sharing his number one stock pick tied to it at no cost.tc pixel

Click here to get Jason Bodner's top pick for free
7/29/2025Sell191$4.37$834.67  
7/22/2025
Kristin Abate
CAO
Sell238$4.00$952.00  
(Data available from 1/1/2013 forward)

KPTI Insider Trading Activity - Frequently Asked Questions

The list of insiders at Karyopharm Therapeutics includes Deepika Pakianathan, Garen G Bohlin, Kristin Abate, Michael Mano, Michael Mason, Reshma Rangwala, Richard A Paulson, Sohanya Roshan Cheng, and Stuart Poulton. Learn more on insiders at KPTI.

1.68% of Karyopharm Therapeutics stock is owned by insiders. Learn more on KPTI's insider holdings.

The following insiders have sold KPTI shares in the last 24 months: Kristin Abate ($5,392.75), Michael Mano ($1,504.62), Reshma Rangwala ($9,222.73), Richard A Paulson ($6,516.00), Sohanya Roshan Cheng ($2,089.75), and Stuart Poulton ($6,465.90).

Insiders have sold a total of 4,049 Karyopharm Therapeutics shares in the last 24 months for a total of $31,191.75 sold.



This page (NASDAQ:KPTI) was last updated on 7/18/2026 by MarketBeat.com Staff.
From Our Partners